Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 2002

View Archived Issues

New data reported for minodronic acid in the treatment of osteolysis and osteoporosis

Potential use of AMG-073 for treating cancer-related hypercalcemia

Pharmacokinetic data reported for extended-release lovastatin

Olpadronate found to promote BMD increase in children with osteogenesis imperfecta

INS-365, a mucin stimulant, effective in a rabbit model of dry eye syndrome

Potential use of Doxil in the treatment of mesothelioma

PEG-rHuMGDF reported to be effective in chronic ITP

Neuroprotective effects reported for minocycline in rat pups

Effects of resveratrol on human myeloid leukemia cell lines

New modulators of immunotherapeutic agents described by Altachem and U. of Alberta

Shionogi describes the isolation of IL-12 production inhibitor from plant

GSK designs new series of Tie2 inhibitors

Novel cannabinoid ligands identified by U.S. university researchers

NCI awards SPORE grant for lymphoma research

Helivax to enter phase II Helicobacter trials

Enzon acquires North American rights to Abelcet

GPC Biotech to codevelop satraplatin with NeoTherapeutics

Roche seeks additional indication for Bondronat in E.U.

Fast track status for tariquidar in NSCLC

Taxoprexin phase III program proceeds

Cephalon reacquires rights to Actiq in key European markets

11-Substituted macrolide and ketolide antibiotics with activity against ERY-resistant bacteria

AC98-6446: a new semisynthetic glycopeptide antibiotic with excellent Gram-positive activity

Small-molecule HCV therapeutics sought in Enanta-Chiron collaboration

ICAAC abstract details mechanism of action, effects in murine model of GVHD for PNP inhibitor

Bristol-Myers Squibb patent covers novel factor Xa inhibitors

Inhibitors of voltage-gated potassium channels in the ICAgen pipeline

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...